301 results on '"Goozner M"'
Search Results
2. A Tale of Two Countries: Lung Cancer Care in Brazil and China
3. Controversy Trails Adaptive Clinical Trials
4. Putting a Price on Hope
5. Drug Shortages Delay Cancer Clinical Trials
6. Expanding Cancer Prevention and Treatment in the Developing World
7. Drug Approvals 2011: Focus on Companion Diagnostics
8. Radiation Example and Cancer: The Japanese Example
9. 9/11 Study on Cancer Risk May Be Premature
10. Stocks' Study Renews Concerns Over Insider Trading on Oncology Drugs
11. From Gene Testing to the Bedside: Workshop Focuses on Future Strategies
12. Avastin Hearing Leads to More Uncertainty Over Drug's Future
13. Duke Scandal Highlights Need for Genomics Research Criteria
14. Accelerated Drug Approval: FDA May Get Tougher; Companies Cite Hurdles
15. Concerns About Provenge Simmer as CMS Ponders Coverage
16. United Healthcare, Five Oncology Practices Try Bundled Payments
17. Oncologists Want FDA To Rethink REMS
18. FDA Increases Focus on Postmarketing Studies
19. Personalizing Ovarian Cancer Screening
20. Ruling on BRCA Gene Patents Could Have Limited Impact
21. Drug Developers Unveil Strategies Aimed at Imatinib-Resistant CML
22. The Proton Beam Debate: Are Facilities Outstripping the Evidence?
23. Big Databases: Outcomes Research Begins To Yield Results
24. Covering cancer: comment on 'cancer and the media'.
25. What are the roles and responsibilities of the media in disseminating health information?
26. Deconstructing medical hype.
27. The value of medical spending in the United States.
28. Private equity takeovers are harming patients.
29. A Much-Needed Corrective on Drug Development Costs.
30. The drug industry's irresponsible price hikes.
31. It's now or never to fix next year's exchange rates.
32. AHCA is an extremist attack on public health.
33. Want to fight chronic disease? Stop subsidizing drug companies.
34. End the slow-walk on payment reform.
35. The phony war on high drug prices.
36. A false start in the fight against opioid addiction.
37. A bold proposal for Trumpcare 2.0.
38. Curing the sickness at the heart of healthcare.
39. Playing with fire on cost-sharing subsidies.
40. Which Scott Gottlieb will run the FDA?
41. It's not that complicated To: President Donald Trump From: HHS Secretary Tom Price Re: It's complicated.
42. 'The software should be a joy to use'.
43. The AHCA's hidden costs will hurt everyone.
44. Trump and Ryan are playing the long game.
45. 'This shift to accountability and value is going to come up in any reform proposal'.
46. Some benefits are essential.
47. The false promise of state-based reform.
48. 'Pricing now appears to more accurately match medical costs'.
49. 'Interoperability continues to be the big issue'.
50. The medical imperative for data-sharing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.